CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment

The success of cancer immunotherapy is limited by resistance to immune checkpoint blockade. We therefore conducted a genetic screen to identify genes that mediated resistance against CTLs in anti-PD-L1 treatment-refractory human tumors. Using PD-L1-positive multiple myeloma cells cocultured with tum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Volpin, Valentina (VerfasserIn) , Michels, Tillmann (VerfasserIn) , Sorrentino, Antonio (VerfasserIn) , Menevse, Ayse N. (VerfasserIn) , Knoll, Gertrud (VerfasserIn) , Ditz, Madlen (VerfasserIn) , Milenkovic, Vladimir M. (VerfasserIn) , Chen, Chih-Yeh (VerfasserIn) , Rathinasamy, Anchana (VerfasserIn) , Griewank, Klaus (VerfasserIn) , Boutros, Michael (VerfasserIn) , Haferkamp, Sebastian (VerfasserIn) , Berneburg, Mark (VerfasserIn) , Wetzel, Christian H. R. (VerfasserIn) , Seckinger, Anja (VerfasserIn) , Hose, Dirk (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Ehrenschwender, Martin (VerfasserIn) , Witzens-Harig, Mathias (VerfasserIn) , Szoor, Arpad (VerfasserIn) , Vereb, Gyorgy (VerfasserIn) , Khandelwal, Nisit (VerfasserIn) , Beckhove, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 14, 2020
In: Cancer immunology research
Year: 2020, Jahrgang: 8, Heft: 9, Pages: 1163-1179
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-19-0608
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/2326-6066.CIR-19-0608
Verlag, lizenzpflichtig, Volltext: https://cancerimmunolres.aacrjournals.org/content/8/9/1163
Volltext
Verfasserangaben:Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N. Menevse, Gertrud Knoll, Madlen Ditz, Vladimir M. Milenkovic, Chih-Yeh Chen, Anchana Rathinasamy, Klaus Griewank, Michael Boutros, Sebastian Haferkamp, Mark Berneburg, Christian H. Wetzel, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Martin Ehrenschwender, Mathias Witzens-Harig, Arpad Szoor, Gyorgy Vereb, Nisit Khandelwal, Philipp Beckhove

MARC

LEADER 00000caa a2200000 c 4500
001 1746743662
003 DE-627
005 20220819093311.0
007 cr uuu---uuuuu
008 210202s2020 xx |||||o 00| ||eng c
024 7 |a 10.1158/2326-6066.CIR-19-0608  |2 doi 
035 |a (DE-627)1746743662 
035 |a (DE-599)KXP1746743662 
035 |a (OCoLC)1341390235 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Volpin, Valentina  |e VerfasserIn  |0 (DE-588)1226189571  |0 (DE-627)1746746122  |4 aut 
245 1 0 |a CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment  |c Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N. Menevse, Gertrud Knoll, Madlen Ditz, Vladimir M. Milenkovic, Chih-Yeh Chen, Anchana Rathinasamy, Klaus Griewank, Michael Boutros, Sebastian Haferkamp, Mark Berneburg, Christian H. Wetzel, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Martin Ehrenschwender, Mathias Witzens-Harig, Arpad Szoor, Gyorgy Vereb, Nisit Khandelwal, Philipp Beckhove 
264 1 |c July 14, 2020 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.02.2021 
520 |a The success of cancer immunotherapy is limited by resistance to immune checkpoint blockade. We therefore conducted a genetic screen to identify genes that mediated resistance against CTLs in anti-PD-L1 treatment-refractory human tumors. Using PD-L1-positive multiple myeloma cells cocultured with tumor-reactive bone marrow-infiltrating CTL as a model, we identified calcium/calmodulin-dependent protein kinase 1D (CAMK1D) as a key modulator of tumor-intrinsic immune resistance. CAMK1D was coexpressed with PD-L1 in anti-PD-L1/PD-1 treatment-refractory cancer types and correlated with poor prognosis in these tumors. CAMK1D was activated by CTL through Fas-receptor stimulation, which led to CAMK1D binding to and phosphorylating caspase-3, -6, and -7, inhibiting their activation and function. Consistently, CAMK1D mediated immune resistance of murine colorectal cancer cells in vivo. The pharmacologic inhibition of CAMK1D, on the other hand, restored the sensitivity toward Fas-ligand treatment in multiple myeloma and uveal melanoma cells in vitro. Thus, rapid inhibition of the terminal apoptotic cascade by CAMK1D expressed in anti-PD-L1-refractory tumors via T-cell recognition may have contributed to tumor immune resistance. 
700 1 |a Michels, Tillmann  |e VerfasserIn  |0 (DE-588)1162738332  |0 (DE-627)1026901162  |0 (DE-576)507602293  |4 aut 
700 1 |a Sorrentino, Antonio  |e VerfasserIn  |0 (DE-588)1239057385  |0 (DE-627)1767081154  |4 aut 
700 1 |a Menevse, Ayse N.  |e VerfasserIn  |4 aut 
700 1 |a Knoll, Gertrud  |e VerfasserIn  |4 aut 
700 1 |a Ditz, Madlen  |e VerfasserIn  |4 aut 
700 1 |a Milenkovic, Vladimir M.  |d 1970-  |e VerfasserIn  |0 (DE-588)132217147  |0 (DE-627)519241223  |0 (DE-576)299011461  |4 aut 
700 1 |a Chen, Chih-Yeh  |e VerfasserIn  |0 (DE-588)117239802X  |0 (DE-627)1041189370  |0 (DE-576)514607041  |4 aut 
700 1 |a Rathinasamy, Anchana  |d 1981-  |e VerfasserIn  |0 (DE-588)142374806  |0 (DE-627)635854082  |0 (DE-576)330385410  |4 aut 
700 1 |a Griewank, Klaus  |d 1978-  |e VerfasserIn  |0 (DE-588)133004112  |0 (DE-627)53008497X  |0 (DE-576)299558223  |4 aut 
700 1 |a Boutros, Michael  |e VerfasserIn  |0 (DE-588)1023031132  |0 (DE-627)717350045  |0 (DE-576)366291831  |4 aut 
700 1 |a Haferkamp, Sebastian  |d 1978-  |e VerfasserIn  |0 (DE-588)132018330  |0 (DE-627)51684296X  |0 (DE-576)298896044  |4 aut 
700 1 |a Berneburg, Mark  |d 1968-  |e VerfasserIn  |0 (DE-588)114943745  |0 (DE-627)390350982  |0 (DE-576)289813859  |4 aut 
700 1 |a Wetzel, Christian H. R.  |d 1966-  |e VerfasserIn  |0 (DE-588)141509686  |0 (DE-627)703997203  |0 (DE-576)324208340  |4 aut 
700 1 |a Seckinger, Anja  |d 1980-  |e VerfasserIn  |0 (DE-588)134177371  |0 (DE-627)562118225  |0 (DE-576)278603734  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Ehrenschwender, Martin  |d 1981-  |e VerfasserIn  |0 (DE-588)13303562X  |0 (DE-627)534471021  |0 (DE-576)299579476  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
700 1 |a Szoor, Arpad  |e VerfasserIn  |4 aut 
700 1 |a Vereb, Gyorgy  |e VerfasserIn  |4 aut 
700 1 |a Khandelwal, Nisit  |e VerfasserIn  |0 (DE-588)1145055699  |0 (DE-627)1006484418  |0 (DE-576)495603228  |4 aut 
700 1 |a Beckhove, Philipp  |d 1969-  |e VerfasserIn  |0 (DE-588)121272842  |0 (DE-627)705350169  |0 (DE-576)292620748  |4 aut 
773 0 8 |i Enthalten in  |t Cancer immunology research  |d Philadelphia, Pa. : AACR, 2013  |g 8(2020), 9, Seite 1163-1179  |h Online-Ressource  |w (DE-627)767120027  |w (DE-600)2732517-9  |w (DE-576)393437752  |x 2326-6074  |7 nnas  |a CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment 
773 1 8 |g volume:8  |g year:2020  |g number:9  |g pages:1163-1179  |g extent:17  |a CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment 
856 4 0 |u https://doi.org/10.1158/2326-6066.CIR-19-0608  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://cancerimmunolres.aacrjournals.org/content/8/9/1163  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210202 
993 |a Article 
994 |a 2020 
998 |g 121272842  |a Beckhove, Philipp  |m 121272842:Beckhove, Philipp  |d 50000  |e 50000PB121272842  |k 0/50000/  |p 23  |y j 
998 |g 1145055699  |a Khandelwal, Nisit  |m 1145055699:Khandelwal, Nisit  |p 22 
998 |g 1050736516  |a Witzens-Harig, Mathias  |m 1050736516:Witzens-Harig, Mathias  |d 910000  |d 910100  |e 910000PW1050736516  |e 910100PW1050736516  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 17 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |e 910000PH139824995  |e 910100PH139824995  |k 0/910000/  |k 1/910000/910100/  |p 16 
998 |g 134177371  |a Seckinger, Anja  |m 134177371:Seckinger, Anja  |p 15 
998 |g 1023031132  |a Boutros, Michael  |m 1023031132:Boutros, Michael  |d 60000  |e 60000PB1023031132  |k 0/60000/  |p 11 
998 |g 142374806  |a Rathinasamy, Anchana  |m 142374806:Rathinasamy, Anchana  |d 910000  |e 910000PR142374806  |k 0/910000/  |p 9 
998 |g 117239802X  |a Chen, Chih-Yeh  |m 117239802X:Chen, Chih-Yeh  |p 8 
998 |g 1239057385  |a Sorrentino, Antonio  |m 1239057385:Sorrentino, Antonio  |d 140000  |e 140000PS1239057385  |k 0/140000/  |p 3 
998 |g 1162738332  |a Michels, Tillmann  |m 1162738332:Michels, Tillmann  |d 140000  |e 140000PM1162738332  |k 0/140000/  |p 2 
999 |a KXP-PPN1746743662  |e 384776005X 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"17 S."}],"recId":"1746743662","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 02.02.2021"],"title":[{"title":"CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment","title_sort":"CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment"}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"July 14, 2020"}],"person":[{"display":"Volpin, Valentina","role":"aut","given":"Valentina","family":"Volpin"},{"family":"Michels","role":"aut","given":"Tillmann","display":"Michels, Tillmann"},{"display":"Sorrentino, Antonio","family":"Sorrentino","role":"aut","given":"Antonio"},{"given":"Ayse N.","role":"aut","family":"Menevse","display":"Menevse, Ayse N."},{"display":"Knoll, Gertrud","role":"aut","given":"Gertrud","family":"Knoll"},{"given":"Madlen","role":"aut","family":"Ditz","display":"Ditz, Madlen"},{"display":"Milenkovic, Vladimir M.","given":"Vladimir M.","role":"aut","family":"Milenkovic"},{"display":"Chen, Chih-Yeh","role":"aut","given":"Chih-Yeh","family":"Chen"},{"display":"Rathinasamy, Anchana","family":"Rathinasamy","role":"aut","given":"Anchana"},{"display":"Griewank, Klaus","given":"Klaus","role":"aut","family":"Griewank"},{"display":"Boutros, Michael","family":"Boutros","role":"aut","given":"Michael"},{"display":"Haferkamp, Sebastian","role":"aut","given":"Sebastian","family":"Haferkamp"},{"family":"Berneburg","role":"aut","given":"Mark","display":"Berneburg, Mark"},{"family":"Wetzel","given":"Christian H. R.","role":"aut","display":"Wetzel, Christian H. R."},{"display":"Seckinger, Anja","given":"Anja","role":"aut","family":"Seckinger"},{"given":"Dirk","role":"aut","family":"Hose","display":"Hose, Dirk"},{"display":"Goldschmidt, Hartmut","given":"Hartmut","role":"aut","family":"Goldschmidt"},{"display":"Ehrenschwender, Martin","family":"Ehrenschwender","given":"Martin","role":"aut"},{"display":"Witzens-Harig, Mathias","family":"Witzens-Harig","role":"aut","given":"Mathias"},{"given":"Arpad","role":"aut","family":"Szoor","display":"Szoor, Arpad"},{"display":"Vereb, Gyorgy","family":"Vereb","role":"aut","given":"Gyorgy"},{"display":"Khandelwal, Nisit","given":"Nisit","role":"aut","family":"Khandelwal"},{"family":"Beckhove","role":"aut","given":"Philipp","display":"Beckhove, Philipp"}],"relHost":[{"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"pubHistory":["1.2013 -"],"name":{"displayForm":["American Association for Cancer Research"]},"part":{"year":"2020","volume":"8","pages":"1163-1179","issue":"9","extent":"17","text":"8(2020), 9, Seite 1163-1179"},"id":{"zdb":["2732517-9"],"eki":["767120027"],"issn":["2326-6074"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"767120027","disp":"CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatmentCancer immunology research","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisherPlace":"Philadelphia, Pa.","publisher":"AACR"}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"illuminating the interplay of cancer and the immune system","title":"Cancer immunology research","title_sort":"Cancer immunology research"}]}],"id":{"doi":["10.1158/2326-6066.CIR-19-0608"],"eki":["1746743662"]},"name":{"displayForm":["Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N. Menevse, Gertrud Knoll, Madlen Ditz, Vladimir M. Milenkovic, Chih-Yeh Chen, Anchana Rathinasamy, Klaus Griewank, Michael Boutros, Sebastian Haferkamp, Mark Berneburg, Christian H. Wetzel, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Martin Ehrenschwender, Mathias Witzens-Harig, Arpad Szoor, Gyorgy Vereb, Nisit Khandelwal, Philipp Beckhove"]}} 
SRT |a VOLPINVALECAMK1DTRIG1420